Apos US Management, Inc.
AposHealth is a pioneering company in the field of non-invasive medical devices, specifically designed to address chronic knee, hip, and lower back pain. Their flagship product, Apos®, is an FDA-cleared device that has been clinically proven to reduce chronic knee pain, particularly in patients with knee osteoarthritis. The device works by retraining the user's gait to alleviate pain and improve mobility, allowing users to wear it for about an hour a day while going about their daily activities. AposHealth is committed to improving the quality of life for its users by providing a personalized treatment approach that is backed by extensive clinical research and recommended by leading health guidelines. The company is passionate about revolutionizing the treatment of musculoskeletal conditions by addressing people's gait to help them alleviate pain, move better, and live better. With a 96% satisfaction rate and over 60 peer-reviewed clinical studies, AposHealth has helped patients worldwide move, live, and thrive.
Industries
Nr. of Employees
medium (51-250)
Apos US Management, Inc.
AposHealth® US office, C/O Studio, 300 Park Ave, 2nd floor, New York, NY 10022
Products
Personalized foot-worn gait retraining device
A customized foot-worn biomechanical device designed to alter the foot contact point and redistribute forces across the lower limb to modify gait and reduce symptomatic joint loading.
Smartphone-based gait assessment application
Mobile application for capturing gait metrics in clinical and outpatient settings validated against laboratory pressure-sensor walkways for remote assessment and monitoring.
Clinical data analytics platform for gait-related treatments
Centralized data platform and analytics capability to aggregate clinical and outcomes data to inform treatment decisions, post-market surveillance, and health-economic reporting.
Personalized foot-worn gait retraining device
A customized foot-worn biomechanical device designed to alter the foot contact point and redistribute forces across the lower limb to modify gait and reduce symptomatic joint loading.
Smartphone-based gait assessment application
Mobile application for capturing gait metrics in clinical and outpatient settings validated against laboratory pressure-sensor walkways for remote assessment and monitoring.
Clinical data analytics platform for gait-related treatments
Centralized data platform and analytics capability to aggregate clinical and outcomes data to inform treatment decisions, post-market surveillance, and health-economic reporting.
Services
Home-based service model providing device delivery, in-home setup or local clinic fitting, clinician onboarding, and structured follow-up within defined service areas.
Programs to integrate partner clinics and clinicians into the treatment model, including referral management, virtual and in-person training modules, and telehealth enablement.
Engagement with payers to present clinical and economic evidence, support coverage decisions, and manage reimbursement programs and funding pathways.
Partnerships for randomized trials, retrospective claims analyses, longitudinal outcome studies, and data sharing to support peer-reviewed publication and evidence generation.
Deployment services and contractual support for implementation within health systems and government agencies, including government supply schedule fulfillment and institutional integration.
Virtual care coordination services and patient activation programs to guide patients through onboarding, therapy adherence, and follow-up.
Home-based service model providing device delivery, in-home setup or local clinic fitting, clinician onboarding, and structured follow-up within defined service areas.
Programs to integrate partner clinics and clinicians into the treatment model, including referral management, virtual and in-person training modules, and telehealth enablement.
Engagement with payers to present clinical and economic evidence, support coverage decisions, and manage reimbursement programs and funding pathways.
Partnerships for randomized trials, retrospective claims analyses, longitudinal outcome studies, and data sharing to support peer-reviewed publication and evidence generation.
Deployment services and contractual support for implementation within health systems and government agencies, including government supply schedule fulfillment and institutional integration.
Virtual care coordination services and patient activation programs to guide patients through onboarding, therapy adherence, and follow-up.
Expertise Areas
- Musculoskeletal biomechanics
- Clinical gait and motion analysis
- Non-invasive biomechanical therapy for knee, hip and lower back conditions
- Clinical trial design and execution, including randomized controlled trials and long-term outcome studies
Key Technologies
- Foot-worn biomechanical device with adjustable proprioceptive elements
- Smartphone-based gait assessment and sensor-based gait capture
- Clinical data aggregation and analytics platform for real-world evidence
- Wearable and mobile sensor-derived spatiotemporal gait metrics
News & Updates
The European Alliance of Associations for Rheumatology (EULAR) has updated its guidelines for the non-pharmacological management of hip and knee osteoarthritis (OA) based on an extensive review.
A recent study published in the Journal of Healthcare Economics Outcomes Research highlights the substantial impact of Apos® on healthcare resource utilization (HCRU) in patients.
AposHealth®, a global leader in musculoskeletal (MSK) solutions, has been recognized with the award from the Pittsburgh Business Group on Health (PBGH) at the 2023 event.
AposHealth® has strengthened its partnership with Professional Physical Therapy to bring a non-invasive, drug-free alternative to surgery to additional Massachusetts locations.
AposHealth® has partnered with three local physical therapy providers to bring New York residents suffering from knee and lower back pain a non-surgical, drug-free solution.
AposHealth® and Ahava Medical & Rehabilitation Center have partnered to bring Brooklyn residents suffering from knee and lower back pain a non-invasive, drug-free alternative to surgery.
The European Alliance of Associations for Rheumatology (EULAR) has updated its guidelines for the non-pharmacological management of hip and knee osteoarthritis (OA) based on an extensive review.
A recent study published in the Journal of Healthcare Economics Outcomes Research highlights the substantial impact of Apos® on healthcare resource utilization (HCRU) in patients.
AposHealth®, a global leader in musculoskeletal (MSK) solutions, has been recognized with the award from the Pittsburgh Business Group on Health (PBGH) at the 2023 event.
AposHealth® has strengthened its partnership with Professional Physical Therapy to bring a non-invasive, drug-free alternative to surgery to additional Massachusetts locations.
AposHealth® has partnered with three local physical therapy providers to bring New York residents suffering from knee and lower back pain a non-surgical, drug-free solution.
AposHealth® and Ahava Medical & Rehabilitation Center have partnered to bring Brooklyn residents suffering from knee and lower back pain a non-invasive, drug-free alternative to surgery.